# NM_014208.3(DSPP):c.3246T>A (p.Ser1082Arg)

https://sugi.bio/variant/dspp-p-ser1082arg

## Summary

**DSPP p.Ser1082Arg (c.3246T>A)** is classified **Uncertain significance** in DSPP (ClinVar, Single submitter, 1 submitter; last evaluated 2026-02-16). AlphaMissense: likely pathogenic (0.6508); Low-frequency (popmax 1.02%, eas); Associated with Inborn genetic diseases.

**At a glance:** Uncertain significance · review: Single submitter · rsID rs780469631 · 1 submitter · 1 linked condition · AlphaMissense likely pathogenic · low-frequency (popmax 1.02%, eas)

## For patients & families {#patients}

This is a change in the DSPP gene that is currently of uncertain significance — a definitive interpretation has not yet been established, submitted by 1 submitter, and is linked to Inborn genetic diseases.

*Reference information, not medical advice, and not a prediction for any individual. A genetic counselor or clinician can interpret what it means for you and your family.*

**Support & next steps:** [Find a genetic counselor (NSGC)](https://findageneticcounselor.nsgc.org/).

## Identity {#identity}

| Field | Value |
| --- | --- |
| Gene | [DSPP](https://sugi.bio/atlas/gene/DSPP/) |
| Protein change (HGVS p.) | p.Ser1082Arg |
| Coding change (HGVS c.) | c.3246T>A |
| dbSNP | [rs780469631](https://www.ncbi.nlm.nih.gov/snp/rs780469631/) |
| Variant type | single nucleotide variant |
| Location | chr4:87615908-87615908 (GRCh38) |
| ClinVar | [VCV2266279](https://www.ncbi.nlm.nih.gov/clinvar/variation/2266279/) |

**All HGVS expressions:** `LRG_1242:g.12380T>A`, `LRG_1242t1:c.3246T>A`, `NC_000004.11:g.88537060T>A`, `NC_000004.12:g.87615908T>A`, `NG_011595.1:g.12380T>A`, `NM_014208.3:c.3246T>A`

## Computational & population evidence {#evidence}

**Concordance:** Mixed / partial computational evidence (see below).

- AlphaMissense **likely pathogenic** (0.6508)
- REVEL 0.264 (benign-leaning) — differs from AlphaMissense
- SaProt LLR -11.581 (damaging) — agrees with AlphaMissense
- → **In-silico consensus:** AlphaMissense and SaProt call this damaging; REVEL does not
- Conservation: phyloP -12.434, GERP -1.67 — fast-evolving / accelerated position
- CADD: **PHRED 5.794**. No single ClinGen-calibrated threshold exists and the expert panels that use CADD disagree — GUCY2D/AIPL1 require ≥ 20.0 for an untranslated-region variant, ABCA4 ≥ 28.1 for a synonymous or indel variant, the Pulmonary Hypertension panel imports Pejaver 2022's missense-calibrated numbers, and the Antibody Deficiencies panel declines CADD entirely for PIK3CD. CADD v1.7 also incorporates Zoonomia phyloP, so it partly re-expresses the conservation above. *Descriptive; no threshold applied.*
- Regional missense constraint: **o/e 0.38** across the covering region of the MANE Select transcript (87,615,660–87,616,173), spanning 513 bp. Chi-square p 9.7e-18. Describes the region, not this allele; gnomAD v4.1.1's own constrained determination. *Descriptive; no ACMG code applied.*
- SpliceAI: **not looked up on this page** — it was served without the gene's SpliceAI index, so no lookup was made. This is a gap in this page, not in the data, and says nothing about whether a splicing effect is predicted.
- Population frequency (gnomAD v4.1): grpmax **1.02%** (eas) · FAF95 0.924% · FAF99 0.885% · 282/27,602 in the highest group · 1,980/937,764 alleles overall — low-frequency (popmax 1.02%, eas).

| Ancestry group | Allele frequency | 1 in |
| --- | --- | --- |
| East Asian (grpmax) | 1.02% | 98 |
| Remaining individuals (not grpmax-eligible) | 0.317% | 315 |
| Ashkenazi Jewish (not grpmax-eligible) | 0.308% | 325 |
| Middle Eastern | 0.271% | 369 |
| Admixed American | 0.267% | 375 |
| Finnish (not grpmax-eligible) | 0.247% | 405 |
| European (non-Finnish) | 0.178% | 560 |
| South Asian | 0.115% | 871 |
| African / African-American | 0.0961% | 1,041 |

*Computational predictors are not independent (ClinGen Variant Classification guidance): AlphaMissense (Cheng et al. 2023) carries the ACMG weight for missense and conservation (phyloP/GERP/phastCons) for non-missense; REVEL (Pejaver-2022 calibrated strength bands) and SaProt (Su et al. 2023, structure-aware, ClinVar-independent protein language model, raw LLR) are shown as orthogonal agreement signals, not additive. For frequency, the gnomAD v4.1 grpmax filtering allele frequency (FAF95) is ClinGen's designated BA1/BS1 input (gnomAD v4 guidance v3.0, June 2025); BA1/BS1 thresholds are disease-specific, not a blanket 5%. Predictions, not a clinical determination.*

## Clinical significance {#significance}

**Uncertain significance** — review status Single submitter *(criteria provided, single submitter)*, last evaluated 2026-02-16.

**Submitter consensus:** unanimous (1/1 Uncertain significance).

### Submitter classifications {#submitters}

| Submitter | Classification | Review | Method | Date |
| --- | --- | --- | --- | --- |
| Ambry Genetics | Uncertain significance | criteria provided, single submitter | clinical testing | 2026-02-16 |

## Associated conditions {#conditions}

[Inborn genetic diseases](https://sugi.bio/atlas/disease/inborn-genetic-diseases/).

**Reported phenotype names (ClinVar):** Inborn genetic diseases.

### Data sources & attribution {#sources}

ClinVar (NCBI — public domain, built 2026-10-11); gnomAD v4.1 (Broad Institute, built 2026-10-06); AlphaMissense (Cheng et al. 2023, © Google DeepMind — CC BY 4.0, built 2026-01-27); REVEL (Ioannidis et al. 2016 — ODbL, built 2026-07-13); SaProt (Su et al. 2023 — MIT, built 2026-07-14); SpliceAI (Illumina — free for non-commercial use, built 2026-10-13); CADD (Rentzsch et al. 2019, University of Washington — free for non-commercial use, built 2026-10-10); Conservation (phyloP/phastCons/GERP) (UCSC hg38 470-way mammal (Hiller Lab) + Ensembl Compara, built 2026-07-12); gnomAD Non-coding Constraint (Gnocchi) (Chen et al. 2024, Broad Institute — CC0, built 2026-10-11); gnomAD Regional Missense Constraint (Broad Institute — CC0, built 2026-10-13); Pangolin (Zeng & Li 2022 — CC BY 4.0, built 2026-10-11); Repeat regions (UCSC — RepeatMasker, TRF, segmental duplications, built 2026-10-11); ClinGen (ClinGen, built 2026-09-22); UniProt (CC BY 4.0); Reactome / GO (CC BY 4.0, built 2026-09-23); MaveDB (per-record license, built 2026-10-11); CIViC (CC0, built 2026-09-22); Orphanet (Orphanet, built 2026-06-12)

*Primary record: NCBI ClinVar (variation 2266279). Classifications reflect these databases as of the page's build date and may change. Free reference use — not medical advice; consult the primary submitters and a clinician.*